Industry News
Scientex adds new agencies
Scientex has recently acquired five new agencies to further bolster the range of products it offers to the scientific community. It has secured exclusive distribution rights for Australia and New Zealand for leading technologies used by scientists across life sciences, industry and research. [ + ]
New York investment mission makes final preparations
AusBiotech is about to host the ‘Australian Life Science Investment Showcase: New York 2012’ prior to the BIO 2012 convention (Boston). [ + ]
Immuron progressing product pipeline
Immuron's (ASX:IMC) top leadership has acknowledged the company's flagging share price, but believe it does not reflect progress made developing two new products. [ + ]
Terry White to stock Cellmid hair growth line
Terry White Chemists has become first pharmacy chain to agree to stock the Evolis hair growth product developed by Cellmid subsidiary Advangen. [ + ]
Phylogica hits new milestone in Pfizer project
Perth-based Phylogica (ASX:PYC) will soon receive the second milestone payment in its peptide drug discovery collaboration with Pfizer. [ + ]
Mark Harvey to focus on driving life science investment with AusBiotech
AusBiotech’s newest board member, Dr Mark Harvey, aims to help drive investment into Australia’s life science sector. [ + ]
Comment: Patent cliff revenues fertilise generics companies
Pharmaceutical companies might be scrambling, but the patent cliff is a boon for generics manufacturers around the world, says GlobalData’s Dr Jerry Isaacson [ + ]
Fusion genes and prostate cancer
Researchers have shown how a mutation found in half of all prostate cancers may lead to disease development and other cancers. [ + ]
Science communication in Australia
How scientifically aware is the Australian public? The scientific community needs to attract students to scientific careers and gain government funding and public support; and to do this effectively, it has to engage the public. Are we doing this? Who knows? Actually, no one really knows. But they are trying to find out and you can help by completing a survey. [ + ]
BioDiem teams for US research on eye disease
BioDiem (ASX:BDM) has entered a collaboration with US researchers for pre-clinical studies into using its compound to fight retinitis pigmentosa. [ + ]
Cheap, abundant cardiomyocytes
A team of Wisconsin scientists has found a way to transform human stem cells - both embryonic and induced pluripotent stem cells - into the critical heart muscle cells by simple manipulation of one key developmental pathway. [ + ]
Dual SKA site welcomed by CSIRO
The international SKA Organisation in Manchester, UK, has announced that the AU$2.5 billion Square Kilometre Array radio telescope will be deployed in Australia-New Zealand, as well as South Africa. [ + ]
Free access to the world’s largest release of comprehensive human cancer genome data
The St Jude Children’s Research Hospital - Washington University Pediatric Cancer Genome Project has announced the largest-ever release of comprehensive human cancer genome data for free access by the global scientific community. [ + ]
Gene muscles in on Type 2 diabetes
Scientists have discovered a gene that appears to regulate muscle development and size. Tweaking it could help treat Type 2 diabetes. [ + ]
AusBiotech announces new Board appointment
AusBiotech today announced the appointment of Dr Mark Harvey to its Board, to join the leadership team of AusBiotech in its efforts to grow and attract capital to the biotechnology industry. [ + ]
